- Thousands of victims were infected by hepatitis C through imported blood
- Breakthrough drug Sofosbuvir was approved by regulator NICE in January
- But NHS England is delaying treatment for patients until at least August
Thousands of patients who contracted a deadly disease through contaminated blood in the biggest scandal in NHS history are being denied a lifesaving drug.
About 7,500 victims are known to have been infected with hepatitis C in the 1970s and 1980s through imported blood products taken from high-risk donors such as prostitutes and prisoners.
A breakthrough drug called Sofosbuvir was approved in January by drugs regulator NICE and patients were told they would have to wait until April to get the ten-week course of tablets, which costs £45,000.
But NHS England has decided on a further delay until August to ensure all patients have equal access to treatment.
No comments:
Post a Comment